Showing 1 - 10 of 73
With the pace of change in the global insurance market showing no signs of slowing in 2020, we have underlined the London Market’s need to reassert its ability to adapt and manage the constant evolution of global risk. Releasing our annual London Market forecast for the year ahead, we have made predictions across 11 areas impacting the London Market, namely: aviation, casualty coverage, construction, cyber, energy, financial lines, marine, product liability and life sciences, professions, political risks and property damage.
The pace of change in the global insurance market has not slowed down in the last 12 months, nor are there any indications of it doing so over the course of the coming year.
This article focuses on electrical consumer units (consumer units) sometimes still referred to as fuse boxes, which distribute the main electrical supply entering a property to individual circuits. As an integral part of any building requiring electricity, we consider some of the potential fire hazards and product liability risks that consumer units can pose.
Boris Johnson’s first Queen’s Speech delivered on Monday 14 October 2019 - dominated by Brexit-related legislation - included the Medicines and Medical Devices Bill (the Bill).
Case review 10/12/2019
Our product liability and life sciences team recently hosted their fifth life sciences conference which focused on emerging risks in innovative healthcare technology.
The UK is the second least supportive nation in their attitude towards the development of unmanned vessels, according to our study across six territories (United Kingdom, United States, Australia, China, Singapore and Hong Kong), and the least supportive of autonomous vehicles more generally.
Lab-grown meat is not just the latest product for environmentally conscious consumers, it also heralds a new type of agriculture and food product design, which could offer attractive risk profiles for insurers that get to know the science.
Case review 14/11/2019
In Bailey & Ors v GlaxoSmithKline “The Seroxat Group Litigation” [08.11.19] the Court of Appeal decided that it was impermissible for the claimants to expand the scope of their pleaded case at trial, which was previously determined at both the case management stage and during the pre-trial review.
Case review 30/10/2019
Supreme Court unanimously concludes that insurers were not liable to pay the uninsured claimants’ costs
Today, the Supreme Court has sensibly overturned the decisions of the lower courts in Travelers in concluding that Travelers’ conduct did not cross the line into ‘unjustified intermeddling’ (per TGA Chapman Limited v Christopher ) in litigation to which it was not a party.